HCM
BLUE

Highbridge Capital Management’s bluebird bio BLUE Stock Holding History

Highbridge Capital Management’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-1,575
Closed -$867K – 1408
2016
Q1 		$867K Buy
+1,575
New +$967K 0.01% 781

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 17.47% 1-Year Est. Return

Highbridge Capital Management's BLUE Position: Q4 2016 in Review

Highbridge Capital Management sold out of bluebird bio (BLUE) in Q4 2016, closing a stake of 611 shares — an estimated $485K sold.

Highbridge Capital Management first reported a position in BLUE in Q2 2015 and held it in 3 quarters. The position peaked at $9.78M in Q2 2015. 199 funds tracked by Wall St. Rank hold BLUE as of Q4 2016.

  • Highbridge Capital Management reported no remaining bluebird bio position as of Q4 2016 after selling out during the quarter.
  • Highbridge Capital Management sold 611 bluebird bio shares in Q4 2016, an estimated $485K.
  • Highbridge Capital Management first reported a position in bluebird bio in Q2 2015 and held it in 3 quarters.
  • Highbridge Capital Management's bluebird bio position peaked at $9.78M in Q2 2015.
  • 199 funds tracked by Wall St. Rank held bluebird bio as of Q4 2016.

Based on Highbridge Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.